CClinicalTrials.gg
Not yet recruitingNCT06015334Updated Aug 29, 2023

Assessment of Visual Performance With Virtual Reality After Cataract Surgery

An interventional study of cataract surgery with implantation of intraocular lens in Cataract, sponsored by The University of Hong Kong. Not yet recruiting. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2023-08-29.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

The proposed randomized clinical trial aims to compare visual performance, measured using VR simulations, in cataract patients implanted either with bilateral trifocal IOL or bilateral monofocal IOL with monovision. The hypothesis is that patients implanted with trifocal IOL would exhibit superior visual performance, in both daytime and nighttime conditions, compared to those with a monofocal IOL with monovision.

Read the detailed description

Cataract surgery provides an opportunity to restore the quality of life by improving vision. While monofocal intraocular lenses (IOLs) implantation with monovision has been a common approach for cataract surgery, it may result in limited clarity at the intermediate distance and reduced depth perception. The advent of multifocal IOLs has expanded the possibilities, potentially offering increased visual performance in different ranges of vision. However, the benefits of multifocal IOLs in everyday activities are not fully understood due to the lack of task-based investigations.

To address this gap, a virtual reality-based approach is proposed to simulate daily activities and assess visual performance. This innovative method can provide insights into how multifocal IOLs enhance activities requiring good binocular vision at varying distances, a capability monofocal IOLs may lack. A randomized clinical trial is suggested to compare the TECNIS Synergy multi-focal IOL with the TECNIS monofocal IOL in monovision. Unlike its bifocal predecessors, the TECNIS Synergy IOL is trifocal, providing clear vision at near, intermediate, and far distances. The hypothesis is that patients implanted with the TECNIS Synergy IOL will demonstrate superior visual performance in simulated day and night conditions compared to those implanted with monofocal IOLs and monovision.

02

Conditions studied

  • Cataract

Browse trials for

Keywords

  • cataract
  • virtual reality
  • multifocal intraocular lens
  • trifocal intraocular lens
  • monovision
03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 114 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Bilateral cataract
  • Regular corneal astigmatism
  • Corneal endothelium cell count >2000 cells/mm2
  • Clear intraocular media other than cataract

Exclusion criteria

Exclusion Criteria:

  • Concomitant ocular diseases
  • Irregular corneal aberration
  • Capsular instability
  • Systemic disease that may affect vision
  • History of other intraocular surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
114 participants (estimated)

Study arms

  • Active comparator
    Bilateral implantation of trifocal intraocular lens

    Patients will receive bilateral implantation of TECNIS Synergy intraocular lens

    Procedure: cataract surgery with implantation of intraocular lens

  • Active comparator
    Bilateral monofocal intraocular lens implantation with monovision

    Patients will receive bilateral implantation of TECNIS monofocal intraocular lens

    Procedure: cataract surgery with implantation of intraocular lens

Interventions

  • Procedurecataract surgery with implantation of intraocular lens

    Cataract surgery with implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.

06

What researchers measure

Primary outcomes

  1. Overall Virtual reality (VR) performance score

    VR performance score measured from all VR simulations

    Time frame: Pre-operation, Month3

Secondary outcomes

  1. Task-specific VR performance score

    VR performance score measured from an individual VR simulation

    Time frame: Pre-operation, Month3

  2. Binocular reading speed assessment

    Reading speed assessed by the MNRead acuity chart

    Time frame: Pre-operation, Month3

  3. Binocular contrast sensitivity

    Contrast sensitivity assessed by Pelli-Robson contrast sensitivity chart

    Time frame: Pre-operation, Month3

  4. Distance visual acuity

    Monocular and binocular uncorrected and corrected distance visual acuity

    Time frame: Pre-operation, Day1, Week1, Month1, Month3

  5. Intermediate (66 cm) visual acuity

    Monocular and binocular uncorrected and distance-corrected intermediate (66 cm) visual acuity

    Time frame: Month3

  6. Near (40 cm) visual acuity

    Monocular and binocular uncorrected and distance-corrected near (40 cm) visual acuity

    Time frame: Month3

  7. Binocular defocus curve

    Binocular defocus curve (from +1.0D to -4.0D) under photopic conditions (85 candela \[cd\]/m2)

    Time frame: Month3

  8. Photic phenomena

    Evaluation of photic phenomena by the 30-item quality of vision questionnaire

    Time frame: Pre-operation, Month3

  9. Quality of life assessment

    National Eye Institute 25-item Visual Function Questionnaire Rasch score

    Time frame: Pre-operation, Month3

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Zhang F, Sugar A, Jacobsen G, Collins M. Visual function and spectacle independence after cataract surgery: bilateral diffractive multifocal intraocular lenses versus monovision pseudophakia. J Cataract Refract Surg. 2011 May;37(5):853-8. doi: 10.1016/j.jcrs.2010.12.041. PubMed 21511153 ↗
  • Mahrous A, Ciralsky JB, Lai EC. Revisiting monovision for presbyopia. Curr Opin Ophthalmol. 2018 Jul;29(4):313-317. doi: 10.1097/ICU.0000000000000487. PubMed 29708928 ↗
  • Chen M, Atebara NH, Chen TT. A comparison of a monofocal Acrysoft IOL using the "blended monovision" formula with the multifocal array IOL for glasses independence after cataract surgery. Ann Ophthalmol (Skokie). 2007 Fall;39(3):237-40. doi: 10.1007/s12009-007-0035-4. PubMed 18025632 ↗
  • Goldberg DG, Goldberg MH, Shah R, Meagher JN, Ailani H. Pseudophakic mini-monovision: high patient satisfaction, reduced spectacle dependence, and low cost. BMC Ophthalmol. 2018 Nov 9;18(1):293. doi: 10.1186/s12886-018-0963-3. PubMed 30413145 ↗
  • Smith CE, Allison RS, Wilkinson F, Wilcox LM. Monovision: Consequences for depth perception from large disparities. Exp Eye Res. 2019 Jun;183:62-67. doi: 10.1016/j.exer.2018.09.005. Epub 2018 Sep 17. PubMed 30237103 ↗
  • Lam AKN, To E, Weinreb RN, Yu M, Mak H, Lai G, Chiu V, Wu K, Zhang X, Cheng TPH, Guo PY, Leung CKS. Use of Virtual Reality Simulation to Identify Vision-Related Disability in Patients With Glaucoma. JAMA Ophthalmol. 2020 May 1;138(5):490-498. doi: 10.1001/jamaophthalmol.2020.0392. PubMed 32191274 ↗
  • Dick HB, Ang RE, Corbett D, Hoffmann P, Tetz M, Villarrubia A, Palomino C, Castillo-Gomez A, Tsai L, Thomas EK, Janakiraman P. Comparison of 3-month visual outcomes of a new multifocal intraocular lens vs a trifocal intraocular lens. J Cataract Refract Surg. 2022 Nov 1;48(11):1270-1276. doi: 10.1097/j.jcrs.0000000000000971. Epub 2022 May 12. PubMed 35545816 ↗
  • Ferreira TB, Ribeiro FJ, Silva D, Matos AC, Gaspar S, Almeida S. Comparison of refractive and visual outcomes of 3 presbyopia-correcting intraocular lenses. J Cataract Refract Surg. 2022 Mar 1;48(3):280-287. doi: 10.1097/j.jcrs.0000000000000743. PubMed 34321410 ↗
  • Ramulu PY, Swenor BK, Jefferys JL, Rubin GS. Description and validation of a test to evaluate sustained silent reading. Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):673-80. doi: 10.1167/iovs.12-10617. PubMed 23258146 ↗
  • Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8. doi: 10.1001/archopht.119.7.1050. PubMed 11448327 ↗
  • Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998 Nov;116(11):1496-504. doi: 10.1001/archopht.116.11.1496. PubMed 9823352 ↗
  • Petrillo J, Cano SJ, McLeod LD, Coon CD. Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples. Value Health. 2015 Jan;18(1):25-34. doi: 10.1016/j.jval.2014.10.005. Erratum In: Value Health. 2015 Jun;18(4):547. PubMed 25595231 ↗

Individual participant data

Plan to share: No — Our plan is focused on publishing the analyzed results of our research through peer-review, journals and conference papers. We understand the importance of patient privacy and confidentiality. Therefore, we will not share any individual patient data with any third parties.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06015334
Lead sponsor
The University of Hong Kong
Collaborators
Janssen, LP
Responsible party
Professor Christopher K.S. Leung (Clinical Professor, The University of Hong Kong) — Principal investigator
First posted
Aug 29, 2023
Start date
Oct 1, 2023 (estimated)
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Aug 29, 2023

Study contacts

ChristopherAnita Yau
Contact
anitayky@hku.hk
39102673
Christopher Leung, MD, MB ChB
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion